Inicio Zine News AZTherapies Completes Enrollment in COGNITE Pivotal Phase 3 Trial of ALZT-OP1 for...

AZTherapies Completes Enrollment in COGNITE Pivotal Phase 3 Trial of ALZT-OP1 for the Treatment of Early Alzheimer’s Disease

1
0

First-in-class candidate targets microglia to slow or halt neuroinflammation and disease progression